Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 57.00
-1.00 (-1.72%)
Apr 3, 2026, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 4.99 billion as of April 2, 2026. Its market cap has decreased by -21.15% in one year.
Market Cap
4.99B
Enterprise Value
2.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
57.00
Market Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 4.99B, a decrease of -91.78%. That is a compound annual growth rate of -35.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 4.99B | 6.10% |
| Dec 30, 2025 | 4.70B | -33.61% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.45B |
| Pharma Foods International | 20.21B |
| Taiko Pharmaceutical | 15.08B |
| Wakamoto Pharmaceutical | 12.28B |
| Morishita Jintan | 9.08B |
| Solasia Pharma K.K. | 8.74B |
| SymBio Pharmaceuticals | 8.11B |
| MedRx | 6.65B |